Quantitative analysis of total β-subunit of human chorionic gonadotropin concentration in urine by immunomagnetic reduction to assist in the diagnosis of ectopic pregnancy

Background The initial diagnosis of ectopic pregnancy depends on physical examination, ultrasound, and serial measurements of total β-subunit of human chorionic gonadotropin (hCGβ) concentrations in serum. The aim of this study was to explore the possibility of using quantitative analysis of total hCGβ in urine rather than in serum by immunomagnetic reduction (IMR) assay as an alternative method to diagnose an ectopic pregnancy. Methods We established a standard calibration curve of IMR intensity against total hCGβ concentration based on standard hCGβ samples, and used an IMR assay to detect total hCGβ concentrations in the urine of pregnant women with lower abdominal pain and/or vaginal bleeding. The final diagnosis of ectopic pregnancy was based on ultrasound scans, operative findings, and pathology reports. In this prospective study, ten clinical samples were used to analyze the relationship of total hCGβ IMR signals between urine and serum. Furthermore, 20 clinical samples were used to analyze the relationship between urine IMR signals and serum levels of total hCGβ. Results The calibration curve extended from 0.01 ng/mL to 10,000 ng/mL with an excellent correlation (R2=0.999). In addition, an excellent correlation of total hCGβ IMR signals between urine and serum was noted (R2=0.994). Furthermore, a high correlation between urine IMR signals and serum levels of total hCGβ was noted (R2=0.862). Conclusion An IMR assay can quantitatively analyze total hCGβ concentrations in urine, and is a potential candidate for point-of-care testing to assist in the diagnosis of ectopic pregnancy.

[1]  D. Levine,et al.  Treatment of ectopic pregnancy: is a human chorionic gonadotropin level of 2,000 mIU/mL a reasonable threshold? , 1997, Radiology.

[2]  T. Chard,et al.  Molecular insights into the structure and function of human chorionic gonadotrophin. , 1993, Journal of molecular endocrinology.

[3]  R. Lequin.  Enzyme immunoassay (EIA)/enzyme-linked immunosorbent assay (ELISA). , 2005, Clinical chemistry.

[4]  N. Kadar.  Serial beta-hCG measurements in the early detection of ectopic pregnancy. , 1990, Obstetrics and gynecology.

[5]  G. Meeks,et al.  Ectopic pregnancy: History, incidence, epidemiology, and risk factors. , 2012, Clinical obstetrics and gynecology.

[6]  R. Dart,et al.  Rate of change of serial beta-human chorionic gonadotropin values as a predictor of ectopic pregnancy in patients with indeterminate transvaginal ultrasound findings. , 1999, Annals of emergency medicine.

[7]  Chia-Chen Chang,et al.  Clinical application of immunomagnetic reduction for quantitative measurement of insulin-like growth factor binding protein-1 in the prediction of pregnant women with preterm premature rupture of membranes. , 2015, Clinica chimica acta; international journal of clinical chemistry.

[8]  K. Barnhart,et al.  Diagnosing Ectopic Pregnancy: Decision Analysis Comparing Six Strategies , 2001, Obstetrics and gynecology.

[9]  N. Zite,et al.  hCG in ectopic pregnancy. , 2012, Clinical obstetrics and gynecology.

[10]  Shieh-Yueh Yang,et al.  Preparation and properties of superparamagnetic nanoparticles with narrow size distribution and biocompatible , 2004 .

[11]  F. Conversano,et al.  Sonographic markers for early diagnosis of fetal malformations. , 2013, World journal of radiology.

[12]  D. Stimpson,et al.  One-step chromatographic immunoassay for qualitative determination of choriogonadotropin in urine. , 1990, Clinical chemistry.

[13]  D A Armbruster,et al.  Limit of detection (LQD)/limit of quantitation (LOQ): comparison of the empirical and the statistical methods exemplified with GC-MS assays of abused drugs. , 1994, Clinical chemistry.

[14]  G. Ross,et al.  Clinical relevance of research on the structure of human chorionic gonadotropin. , 1977, American journal of obstetrics and gynecology.

[15]  M. Miodovnik,et al.  Human chorionic gonadotropin (beta-subunit) in the early diagnosis of ectopic pregnancy. , 1978, Obstetrics and gynecology.

[16]  Chia-Chen Chang,et al.  IMMUNOMAGNETIC REDUCTION FOR FETAL FIBRONECTIN DETECTION | A NOVEL METHOD TO DETECT THE PRETERM BIOMARKER , 2011 .

[17]  B. Potter,et al.  Diagnosis and management of ectopic pregnancy. , 2005, American family physician.

[18]  Study of the temperature dependent immuno-reaction kinetics for the bio-functionalized magnetic nanoparticle assay of bio-markers of colorectal cancer , 2014 .

[19]  Hsiu-Li Lin,et al.  Use of immunomagnetic reduction for C-reactive protein assay in clinical samples , 2012, International journal of nanomedicine.

[20]  A. Purdie.  Ectopic pregnancy. , 1963, The Practitioner.

[21]  G. Braunstein,et al.  Differences in total human chorionic gonadotropin immunoassay analytical specificity and ability to measure human chorionic gonadotropin in gestational trophoblastic disease and germ cell tumors. , 2010, The Journal of reproductive medicine.

[22]  F. Proverbio,et al.  Bioactivity of Serum hCG in Preeclampsia , 2001, Obstetrics and gynecology.

[23]  Ming-Jang Chiu,et al.  Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease. , 2013, ACS chemical neuroscience.

[24]  K. Chung,et al.  The use of serial human chorionic gonadotropin levels to establish a viable or a nonviable pregnancy. , 2008, Seminars in reproductive medicine.

[25]  N. Wald,et al.  Assessment of the value of reporting partial screening results in prenatal screening for Down syndrome , 2001, Prenatal diagnosis.

[26]  John Lewis.  Presumed diagnosis of ectopic pregnancy. , 2003, Obstetrics and gynecology.

[27]  S. Nakajima,et al.  Secretion and excretion of human chorionic gonadotropin during early pregnancy. , 2005, Fertility and sterility.

[28]  K. Barnhart.  Clinical practice. Ectopic pregnancy. , 2009, The New England journal of medicine.

[29]  P. Bossuyt,et al.  Serum human chorionic gonadotropin measurement in the diagnosis of ectopic pregnancy when transvaginal sonography is inconclusive. , 1998, Fertility and sterility.

[30]  R. de Hertogh,et al.  Rapid, automated quantification of total human chorionic gonadotropin in serum by a chemiluminescent enzyme immunometric assay. , 1995, Clinical chemistry.

[31]  Chin-Yih Hong,et al.  Wash-free, antibody-assisted magnetoreduction assays of orchid viruses. , 2008, Journal of virological methods.

[32]  Jen-Jie Chieh,et al.  Feasibility studies for assaying alpha-fetoprotein using antibody-activated magnetic nanoparticles , 2012, International journal of nanomedicine.